Home Infusion Therapy Devices Market Size

ID: MRFR/HC/6434-HCR

200 Pages

Rahul Gotadki

February 2026

Home Infusion Therapy Devices Market Research Report By Device Type (Infusion Pumps, IV Sets, Needles and Cannulas, Syringe Pumps, Infusion Accessories), By Application (Antibiotics, Chemotherapy, Enteral Nutrition, Pain Management, Hydration Therapy), By End User (Hospitals, Homecare Settings, Ambulatory Surgical Centers, Nursing Homes), By Product (Portable Infusion Devices, Complex Infusion Systems, Smart Infusion Pumps, Accessories) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) -Forecast to 2035

Home Infusion Therapy Devices Market Infographic

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Home Infusion Therapy Devices Size

Home Infusion Therapy Devices Market Growth Projections and Opportunities

The rising maturing population overall is a huge market factor for home infusion therapy devices. As individuals age, there is a higher prevalence of persistent infections that require long haul treatment, encouraging an interest for helpful and home-based infusion arrangements. The rising incidence of constant sicknesses like cancer, diabetes, and immune system problems adds to the development of the Home Infusion Therapy Devices market. These circumstances frequently require constant medicine organization, making home infusion a revered and financially smart option in contrast to emergency clinic-based medicines. The worldwide medical services scene is moving towards a worth based model, underscoring cost-viability and patient results. Home infusion therapy lines up with this pattern by decreasing hospitalization costs and working on quiet fulfillment, driving the reception of infusion devices intended for home use. The inclination for getting clinical medicines in the solace of one's home is a significant component driving the interest for home infusion therapy. Patients frequently favor the accommodation and commonality of home settings, prompting expanded acknowledgment and use of infusion devices for home consideration. Developing awareness among both medical care experts and patients about the advantages of home infusion therapy adds to market extension. Instructive drives and awareness campaigns assist with scattering fantasies and misunderstandings, advancing the comprehension of the security and adequacy of home-based infusion. The Coronavirus pandemic has highlighted the significance of home-based medical services arrangements, including infusion therapy. Patients and medical services suppliers have progressively looked for options in contrast to face-to-face clinic visits, driving the interest for Home Infusion Therapy Devices as a more secure and more helpful choice.

Home Infusion Therapy Devices Market Size Graph

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

FAQs

What is the projected market valuation of the Home Infusion Therapy Devices Market by 2035?

The projected market valuation for the Home Infusion Therapy Devices Market is expected to reach 11.79 USD Billion by 2035.

What was the market valuation of the Home Infusion Therapy Devices Market in 2024?

The overall market valuation of the Home Infusion Therapy Devices Market was 6.83 USD Billion in 2024.

What is the expected CAGR for the Home Infusion Therapy Devices Market during the forecast period 2025 - 2035?

The expected CAGR for the Home Infusion Therapy Devices Market during the forecast period 2025 - 2035 is 5.09%.

Which device type segment is projected to have the highest valuation by 2035?

The Smart Infusion Pumps segment is projected to reach a valuation of 4.0 USD Billion by 2035.

How does the Homecare Settings segment compare to Hospitals in terms of market valuation by 2035?

By 2035, the Homecare Settings segment is expected to reach 4.2 USD Billion, surpassing the Hospitals segment, which is projected at 3.5 USD Billion.

What are the key applications driving growth in the Home Infusion Therapy Devices Market?

Key applications driving growth include Hydration Therapy, projected to reach 3.59 USD Billion, and Antibiotics, expected to reach 2.5 USD Billion by 2035.

Which companies are considered key players in the Home Infusion Therapy Devices Market?

Key players in the market include Baxter International Inc., B. Braun Melsungen AG, and Fresenius Kabi AG, among others.

What is the projected valuation for the IV Sets segment by 2035?

The IV Sets segment is projected to reach a valuation of 2.5 USD Billion by 2035.

How does the market for Portable Infusion Devices compare to Smart Infusion Pumps by 2035?

By 2035, the Portable Infusion Devices segment is expected to reach 2.5 USD Billion, while Smart Infusion Pumps are projected to reach 4.0 USD Billion.

What is the anticipated growth trend for the Needles and Cannulas segment in the Home Infusion Therapy Devices Market?

The Needles and Cannulas segment is anticipated to grow to 1.8 USD Billion by 2035, indicating a positive growth trend.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per Market Research Future analysis, the Home Infusion Therapy Devices Market was estimated at 6.83 USD Billion in 2024. The Home Infusion Therapy Devices industry is projected to grow from 7.178 USD Billion in 2025 to 11.79 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.0% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Home Infusion Therapy Devices Market is experiencing robust growth driven by technological advancements and a shift towards home healthcare.

North America remains the largest market for home infusion therapy devices, driven by high healthcare expenditure and advanced medical infrastructure. The Asia-Pacific region is emerging as the fastest-growing market, fueled by increasing healthcare access and rising patient awareness. Infusion pumps dominate the market as the largest segment, while IV sets are witnessing rapid growth due to their essential role in home care settings. Key market drivers include technological advancements in home infusion therapy devices and the aging population, which necessitates more home healthcare solutions.

Home Infusion Therapy Devices Market

CAGR

5.09%

Market Size & Forecast

2024 Market Size	6.83 (USD Billion)
2035 Market Size	11.79 (USD Billion)
CAGR (2025 - 2035)	5.09%
Largest Regional Market Share in 2024	North America

Major Players

<a href="https://ushospitalproducts.baxter.com/alternate-sites/home-infusion">Baxter International Inc.</a> (US), B. Braun Melsungen AG (DE), Fresenius Kabi AG (DE), Medtronic plc (IE), Smiths Medical (US), Terumo Corporation (JP), ICU Medical, Inc. (US), Halyard Health, Inc. (US)

Market Trends

The Home Infusion Therapy Devices Market is currently experiencing a notable transformation, driven by advancements in technology and an increasing preference for at-home healthcare solutions. This shift is largely influenced by the growing prevalence of chronic diseases, which necessitate ongoing treatment and management. As patients seek more comfortable and convenient options, the demand for home infusion devices is likely to rise. Furthermore, the integration of smart technology into these devices appears to enhance patient monitoring and adherence to treatment protocols, thereby improving overall health outcomes. In addition, the Home Infusion Therapy Devices Market is witnessing a surge in investment from various stakeholders, including healthcare providers and technology firms. This influx of capital is expected to foster innovation, leading to the development of more efficient and user-friendly devices. Regulatory bodies are also adapting to these changes, potentially streamlining the approval processes for new products. As a result, the market landscape is evolving, with a focus on enhancing patient experience and ensuring safety. Overall, the future of the Home Infusion Therapy Devices Market seems promising, with numerous opportunities for growth and development on the horizon.

Technological Advancements

The Home Infusion Therapy Devices Market is increasingly influenced by rapid technological innovations. Devices are becoming more sophisticated, incorporating features such as wireless connectivity and automated dosing systems. These advancements not only improve the efficiency of treatments but also enhance patient safety and comfort.

Shift Towards Home Healthcare

There is a discernible trend towards home healthcare solutions, as patients prefer receiving treatments in familiar environments. This shift is driven by the desire for convenience and the potential for reduced healthcare costs. Consequently, the Home Infusion Therapy Devices Market is adapting to meet these evolving patient needs.

Increased Investment in R&D

Investment in research and development within the Home Infusion Therapy Devices Market is on the rise. Stakeholders are recognizing the importance of innovation in creating effective and user-friendly devices. This focus on R&D is likely to lead to the introduction of novel products that cater to diverse patient requirements.

Home Infusion Therapy Devices Market Market Drivers

Increased Investment in R&D

The Home Infusion Therapy Devices Market is benefiting from increased investment in research and development, which is crucial for driving innovation and improving product offerings. Companies are allocating significant resources to develop advanced infusion systems that cater to diverse patient needs. This investment is reflected in the growing number of patents filed in the infusion device sector, indicating a competitive landscape focused on enhancing device functionality and safety. Furthermore, the market is projected to witness a growth rate of around 7% annually, driven by these R&D efforts. As manufacturers strive to create more efficient and user-friendly devices, the overall quality of home infusion therapies is expected to improve, thereby attracting more patients to opt for home-based treatments.

Shift Towards Home Healthcare

The Home Infusion Therapy Devices Market is witnessing a notable shift towards home healthcare, driven by the increasing preference for at-home treatment options among patients. This trend is largely influenced by the desire for comfort, convenience, and cost-effectiveness. As healthcare systems evolve, more patients are opting for home-based therapies, which reduces hospital stays and associated costs. Data suggests that the home healthcare market is expected to reach a valuation of over 300 billion by 2025, indicating a substantial opportunity for home infusion therapy devices. This shift not only empowers patients but also alleviates the burden on healthcare facilities, thereby fostering a favorable environment for the growth of home infusion therapy devices.

Aging Population and Chronic Diseases

The Home Infusion Therapy Devices Market is significantly influenced by the aging population and the rising prevalence of chronic diseases. As the global demographic shifts towards an older population, the demand for home infusion therapies is likely to increase. Older adults often require long-term medication management, which can be effectively administered through home infusion devices. Additionally, chronic conditions such as diabetes and cancer necessitate ongoing treatment, further propelling the need for these devices. Recent statistics indicate that nearly 60% of older adults manage at least one chronic condition, underscoring the potential market for home infusion therapy devices. This demographic trend suggests a sustained demand for innovative solutions that facilitate at-home care.

Regulatory Support and Reimbursement Policies

The Home Infusion Therapy Devices Market is positively impacted by favorable regulatory support and reimbursement policies that encourage the adoption of home infusion therapies. Governments and health organizations are increasingly recognizing the benefits of home-based treatments, leading to the establishment of guidelines that facilitate the use of infusion devices in home settings. Moreover, reimbursement policies are evolving to cover home infusion therapies, making them more accessible to patients. This regulatory environment is expected to enhance market growth, as it reduces financial barriers for patients seeking home infusion options. As reimbursement frameworks continue to expand, the market for home infusion therapy devices is likely to flourish, providing patients with more treatment choices.

Technological Advancements in Home Infusion Therapy Devices

The Home Infusion Therapy Devices Market is experiencing a surge in technological advancements that enhance the efficacy and safety of infusion therapies. Innovations such as smart infusion pumps, which integrate with mobile applications, allow for real-time monitoring and adjustments, thereby improving patient outcomes. Furthermore, the incorporation of artificial intelligence in these devices aids in predicting potential complications, thus ensuring timely interventions. According to recent data, the infusion pump segment is projected to grow at a compound annual growth rate of approximately 8% over the next few years. This trend indicates a robust demand for advanced devices that not only streamline the infusion process but also provide healthcare professionals with critical data to make informed decisions.

Market Segment Insights

By Device Type: Infusion Pumps (Largest) vs. IV Sets (Fastest-Growing)

The Home Infusion Therapy Devices Market has seen a significant distribution of market share among its various device types. Infusion Pumps dominate the market as the largest segment, driven by their essential role in delivering medication accurately and controlling infusion rates. IV Sets also play a substantial role, providing the critical pathway for fluid and medication delivery during home therapy treatments. The presence of these devices ensures a comprehensive range of options for healthcare providers and patients alike. In terms of growth trends, IV Sets are emerging as the fastest-growing segment due to the increasing demand for convenient and effective home care solutions. The rise in chronic diseases requiring long-term infusion therapy, coupled with a growing preference for home-based healthcare, is propelling this growth. Additionally, advancements in technology that enhance the safety and ease of use of these devices are further driving market expansion. The shift towards patient-centric care models is pivotal in shaping these trends.

Infusion Pumps (Dominant) vs. Syringe Pumps (Emerging)

Infusion Pumps have established themselves as the dominant segment in the Home Infusion Therapy Devices Market, characterized by their high precision and versatility in administering a wide range of medications. They are essential for managing complex therapies, making them invaluable for patients with chronic conditions requiring ongoing treatment. In contrast, Syringe Pumps are viewed as an emerging segment, becoming increasingly popular for their compact design and ability to administer small volumes of medications efficiently. This segment is gaining attention in home healthcare settings, particularly for pediatric and oncology patients, where dosing accuracy is critical. The advancement in miniaturized technology and user-friendly interfaces is further enhancing the appeal of Syringe Pumps, establishing their foothold in the market.

By Application: Antibiotics (Largest) vs. Chemotherapy (Fastest-Growing)

In the Home Infusion Therapy Devices Market, the application of antibiotics represents the largest segment due to the rising prevalence of chronic infections and the increasing demand for outpatient care. This segment is primarily driven by a growing patient population requiring long-term antibiotic therapy, making it a staple in home healthcare settings. Chemotherapy, on the other hand, is emerging as a fast-growing segment as more cancer patients prefer home care solutions to reduce hospital visits and improve their quality of life. The shift towards at-home treatment options is contributing to its rapid expansion.

Antibiotics (Dominant) vs. Chemotherapy (Emerging)

Antibiotics dominate the Home Infusion Therapy Devices Market due to their critical role in managing infectious diseases, particularly in patients with long-term health conditions. This segment benefits from advancements in home healthcare technology, enabling efficient and safe medication administration in non-hospital settings. Conversely, chemotherapy as an emerging segment reflects a growing trend of cancer patients seeking outpatient care. This shift is characterized by increased support from healthcare providers for home administration, ensuring patients receive their treatments in a more comfortable environment while maintaining quality care and minimizing hospital stays.

By End User: Homecare Settings (Largest) vs. Hospitals (Fastest-Growing)

In the Home Infusion Therapy Devices Market, Homecare Settings currently hold the largest market share among end users, attributed to the rising preference for home-based healthcare solutions. This trend is driven by advancements in technology that enable effective monitoring and management of treatments from home, leading to increased patient satisfaction and reduced healthcare costs. Hospitals, while they represent a significant portion of the market, are categorized as the fastest-growing segment due to their increasing adoption of innovative infusion therapy solutions.

Homecare Settings: Dominant vs. Hospitals: Emerging

Homecare Settings dominate the Home Infusion Therapy Devices Market, offering patients the convenience of receiving treatments in the comfort of their own homes. This segment is characterized by a patient-centered approach, integrating advanced infusion technologies that ensure accurate dosage and enhance patient safety. Services are often bundled with remote monitoring and support, significantly improving treatment adherence. In contrast, Hospitals represent an emerging segment, rapidly embracing the latest infusion technologies to enhance patient care and operational efficiencies. Their investment in sophisticated infusion systems aligns with the growing emphasis on personalized and efficient medical care, thereby changing the landscape of therapeutic treatments.

By Product: Smart Infusion Pumps (Largest) vs. Portable Infusion Devices (Fastest-Growing)

In the Home Infusion Therapy Devices Market, the Product segment is primarily dominated by Smart Infusion Pumps, which hold the largest market share due to their advanced features and widespread adoption among healthcare providers. Portable Infusion Devices are emerging rapidly, fueled by increasing demand for home healthcare solutions, enabling patients to receive care in comfort. Complex Infusion Systems and Accessories contribute significantly to the market landscape, providing essential support and versatility in infusion therapy.

Smart Infusion Pumps (Dominant) vs. Portable Infusion Devices (Emerging)

Smart Infusion Pumps are renowned for their precision, programmable features, and integration capabilities with healthcare systems, making them ideal for complex medication regimens in home settings. They facilitate better patient management and enhance safety through alarm systems and real-time monitoring. On the other hand, Portable Infusion Devices represent the emerging trend, appealing to patients seeking flexibility and mobility in their treatment plans. These devices are lightweight, user-friendly, and designed to accommodate a variety of infusion therapies, thus meeting the growing need for at-home medical care.

Get more detailed insights about Home Infusion Therapy Devices Market Research Report-Forecast to 2035

Regional Insights

North America emerges as a dominant player in this market, with a valuation of 3.8 USD Billion in 2024 and expected growth to 6.5 USD Billion by 2035, representing a majority holding of the market due to its advanced healthcare infrastructure and strong focus on home-based therapies. Europe follows with a market valuation of 1.8 USD Billion in 2024, projected to reach 3.2 USD Billion in 2035, benefiting from an increasing geriatric population and favorable reimbursement policies.

The Asia-Pacific (APAC) region is expected to grow substantially, starting with a valuation of 1.5 USD Billion in 2024 and increasing to 2.7 USD Billion by 2035, driven by rising healthcare expenditures and significant advancements in medical technologies. South America, while smaller, shows growth potential with a valuation of 0.8 USD Billion in 2024 and 1.2 USD Billion by 2035, reflecting improvements in healthcare accessibility.

The Middle East and Africa (MEA) represent the least dominant segment, starting at 0.3 USD Billion in 2024 and expected to reach 0.7 USD Billion by 2035, often challenged by varying healthcare standards and resource availability.Overall, these insights showcase the diverse landscape of the Global Home Infusion Therapy Devices Market across regional fronts, with each segment’s growth fueled by specific local trends and healthcare needs.

Key Players and Competitive Insights

The competitive landscape of the Global Home Infusion Therapy Devices Market has been evolving significantly, driven by the increasing demand for home healthcare services and advancements in technology. This market encompasses a range of devices catering to patients requiring intravenous therapy at home, including infusion pumps, administration sets, and other ancillary devices. As healthcare moves towards patient-centric models, companies in this sector are focusing on innovation, enhancing patient safety, and improving user experience.
Competition is shaped by the ability of these companies to develop efficient and reliable solutions that meet regulatory standards while maintaining cost-effectiveness. As a result, strong market players are increasingly investing in research and development, forging strategic alliances, and expanding their product portfolios to capture a larger market share.Nipro Corporation stands out in the Global Home Infusion Therapy Devices Market due to its robust manufacturing capabilities and a wide range of high-quality infusion products. The company has developed a reputation for its reliable infusion systems that cater to the specific needs of home healthcare providers.
With an extensive distribution network and a commitment to technological advancement, Nipro Corporation is well-positioned to leverage its strengths in product innovation.
The company's strategic focus on enhancing the user-friendliness and safety of its devices ensures that it retains a competitive edge in this rapidlygrowing market. Additionally, Nipro Corporation emphasizes quality control and customer service, optimizing its operations to ensure customer satisfaction while expanding its global footprint.Hospira, a key player in the Global Home Infusion Therapy Devices Market, offers a diverse range of infusion products, including both pumps and software solutions designed to support at-home patients.
The company is recognized for its commitment to quality and safety, which has enabled it to build a strong market presence in various regions. Hospira's strengths lie in its innovative product offerings and its ability to navigate complex regulatory landscapes efficiently. The company has engaged in strategic mergers and acquisitions to bolster its product capabilities and expand its global reach. By focusing on enhancing patient safety through advanced technology and responding to the growing need for at-home therapies, Hospira is well-positioned to meet the demands of the evolving healthcare landscape while continuing to strengthen its market position.

Key Companies in the Home Infusion Therapy Devices Market include

Industry Developments

The Global Home Infusion Therapy Devices Market has witnessed significant advancements and developments in recent months. Companies such as Fresenius Kabi and Baxter International have been focusing on expanding their product lines, enhancing patient comfort, and improving the efficacy of therapies. For instance, in October 2023, Baxter International launched an innovative infusion system designed to improve the administration of intravenous therapies in home settings. In terms of mergers and acquisitions, no recent transactions involving companies like Nipro Corporation, Hospira, Grifols, Terumo Corporation, and others have been publicly announced in recent months.

However, major market players are actively investing in partnerships to boost technological capabilities and market reach. The market is projected to grow due to increasing geriatric populations and the rise in chronic diseases, with a notable valuation increase over the past two years attributed to heightened demand for at-home healthcare and improved healthcare policies supporting home care. Regulatory bodies have also been emphasizing the need for safe and efficient home infusion systems, positively influencing innovation and market growth. These developments underscore the ongoing transformation of the home infusion therapy landscape on a global scale.

Future Outlook

Home Infusion Therapy Devices Market Future Outlook

The Home Infusion Therapy Devices Market is projected to grow at a 5.09% CAGR from 2025 to 2035, driven by technological advancements, increasing chronic diseases, and a shift towards home healthcare.

New opportunities lie in:

Development of portable infusion pumps for home use
Integration of telehealth solutions with infusion devices
Expansion of training programs for home healthcare providers

By 2035, the market is expected to be robust, reflecting substantial growth and innovation.

Market Segmentation

Home Infusion Therapy Devices Market Product Outlook

Portable Infusion Devices
Complex Infusion Systems
Smart Infusion Pumps
Accessories

Home Infusion Therapy Devices Market End User Outlook

Hospitals
Homecare Settings
Ambulatory Surgical Centers
Nursing Homes

Home Infusion Therapy Devices Market Application Outlook

Antibiotics
Chemotherapy
Enteral Nutrition
Pain Management
Hydration Therapy

Home Infusion Therapy Devices Market Device Type Outlook

Infusion Pumps
IV Sets
Needles and Cannulas
Syringe Pumps
Infusion Accessories

Report Scope

MARKET SIZE 2024	6.83(USD Billion)
MARKET SIZE 2025	7.178(USD Billion)
MARKET SIZE 2035	11.79(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.09% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Baxter International Inc. (US), B. Braun Melsungen AG (DE), Fresenius Kabi AG (DE), Medtronic plc (IE), Smiths Medical (US), Terumo Corporation (JP), ICU Medical, Inc. (US), Halyard Health, Inc. (US)
Segments Covered	Device Type, Application, End User, Product, Regional
Key Market Opportunities	Integration of advanced digital health technologies enhances patient monitoring in the Home Infusion Therapy Devices Market.
Key Market Dynamics	Rising demand for home healthcare drives innovation and competition in home infusion therapy devices.
Countries Covered	North America, Europe, APAC, South America, MEA